Aprea Therapeutics Inc (APRE)
3.972
+0.05
(+1.32%)
USD |
NASDAQ |
Nov 04, 16:00
Aprea Therapeutics Total Assets (Quarterly): 29.96M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 29.96M |
March 31, 2024 | 33.20M |
December 31, 2023 | 22.65M |
September 30, 2023 | 25.77M |
June 30, 2023 | 28.68M |
March 31, 2023 | 32.02M |
December 31, 2022 | 30.16M |
September 30, 2022 | 33.62M |
June 30, 2022 | 40.68M |
March 31, 2022 | 50.34M |
December 31, 2021 | 56.82M |
Date | Value |
---|---|
September 30, 2021 | 62.48M |
June 30, 2021 | 71.55M |
March 31, 2021 | 80.39M |
December 31, 2020 | 92.81M |
September 30, 2020 | 102.83M |
June 30, 2020 | 114.82M |
March 31, 2020 | 125.13M |
December 31, 2019 | 133.61M |
September 30, 2019 | 57.34M |
June 30, 2019 | 62.21M |
December 31, 2018 | 66.02M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
22.65M
Minimum
Dec 2023
133.61M
Maximum
Dec 2019
61.45M
Average
50.34M
Median
Mar 2022
Total Assets (Quarterly) Benchmarks
Aethlon Medical Inc | 11.42M |
Brainstorm Cell Therapeutics Inc | 5.683M |
NovaBay Pharmaceuticals Inc | 3.925M |
Palatin Technologies Inc | 10.74M |
iBio Inc | 28.73M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 4.405M |
Shareholders Equity (Quarterly) | 25.56M |